相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
Arjun Majithia et al.
CIRCULATION (2021)
Hypocholesterolemia is a risk factor for reduced systemic vascular resistance reactivity during hemodialysis
Miki Matsuo et al.
HYPERTENSION RESEARCH (2021)
Society Guidelines 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Glen J. Pearson et al.
CANADIAN JOURNAL OF CARDIOLOGY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Statins and All-Cause Mortality in Patients Undergoing Hemodialysis
Jaehun Jung et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients
Wenkai Xia et al.
BMC NEPHROLOGY (2020)
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
Baris Gencer et al.
LANCET (2020)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jordan Fulcher et al.
LANCET (2019)
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
David M. Charytan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study
Na Hao et al.
BMC NEPHROLOGY (2019)
2018 Guidelines for the management of dyslipidemia
Fun-Jung Rhee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2019)
Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept
Hae Young Chung et al.
AGING AND DISEASE (2019)
Impact of Lipids on Cardiovascular Health JACC Health Promotion Series
Brian A. Ference et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cholesterol Metabolism in CKD
Allison B. Reiss et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention
Goran Loncar et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2015)
Meta-analysis of statin therapy in maintenance dialysis patients
Ling Sun et al.
RENAL FAILURE (2015)
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease
Allan J. Collins et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2015)
Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline
Marcello Tonelli et al.
ANNALS OF INTERNAL MEDICINE (2014)
Nontraditional Serum Lipid Variables and Recurrent Stroke Risk
Jong-Ho Park et al.
STROKE (2014)
Association between LDL-C and Risk of Myocardial Infarction in CKD
Marcello Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Sudden Cardiac Death in End-Stage Renal Disease Patients A 5-Year Prospective Analysis
Angela Yee-Moon Wang et al.
HYPERTENSION (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Association of LDL Cholesterol and Inflammation With Cardiovascular Events and Mortality in Hemodialysis Patients With Type 2 Diabetes Mellitus
Vera Krane et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?
E. M. El-Shafey et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2008)
Chronic kidney disease management in the United Kingdom: NEOERICA project results
P. E. Stevens et al.
KIDNEY INTERNATIONAL (2007)
Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
H Honda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients
NA Mason et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Association between cholesterol level and mortality in - Role of inflammation dialysis patients and malnutrition
YM Liu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients
T Shoji et al.
KIDNEY INTERNATIONAL (2004)
Managing dyslipidemia in chronic kidney disease
DE Weiner et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality
GM London et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
K Iseki et al.
KIDNEY INTERNATIONAL (2002)
Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease
J Jeppesen et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
分享论文
